Cyclopropane

Cyclopropane

SCHEMBL365424

C1CC1.O=S(=O)(Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclooctane SCHEMBL27515472 1.00 CA1 (0.33)
Cyclohexane SCHEMBL3105735 1.00 CA1 (0.33)
Cyclopentane SCHEMBL2198075 1.00 CA1 (0.33)
SCHEMBL11357022 1.00
SCHEMBL254 0.82
SCHEMBL6681816 0.82
SCHEMBL9540531 0.82
SCHEMBL27986358 0.82 CA5A (0.33)
Cyclopropane SCHEMBL28876799 0.80
Cyclohexane SCHEMBL11777586 0.80 CA5A (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160298-A Tacrine-sulfonamide derivative and preparation method and application thereof 中国人民解放军北部战区总医院 2022-10-11 CN claimed
EP-4739684-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP disclosed
US-20260109711-A1 MACROCYCLIC SULFONAMIDE MODULATORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2026-04-23 US disclosed
EP-4261213-B1 FGFR INHIBITOR COMPOUND AND USE THEREOF SHENZHEN KANGSU PHARMACEUTICAL TECH CO LTD (CN) 2026-04-15 EP disclosed
EP-4713095-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS Chengdu Anticancer Bioscience, Ltd. (CN) 2026-03-25 EP disclosed
US-12583836-B2 Sulphonamide compounds Anaxis Pharma Pty Ltd (AU) 2026-03-24 US disclosed
EP-4701735-A1 HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR Nested Therapeutics, Inc. (US) 2026-03-04 EP disclosed
US-12540130-B2 Substituted pyrrolidine amides IV GRUENENTHAL GMBH (DE) 2026-02-03 US disclosed
US-20260022102-A1 1,2,4-Oxadiazole and Thiadiazole Compounds as Immunomodulators AURIGENE ONCOLOGY LIMITED (IN) 2026-01-22 US disclosed
US-20250289811-A1 HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. 2025-09-18 US disclosed
CN-1938311-A Macrocyclic compounds as inhibitors of viral replication INTERMUNE INC (US) 2007-03-28 CN disclosed
CN-1747955-A Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2006-03-15 CN disclosed
CN-1220676-C Method for producing acid anhydride TOKUYAMA CORP (JP) 2005-09-28 CN disclosed
CN-1617855-A Cytosolic phospholipase A2Inhibitors WYETH CORP (US) 2005-05-18 CN disclosed
CN-1186328-C Substd. 5-benzyl-2,4-diaminopyrimidines BASLIDE PHARMA AG (CH) 2005-01-26 CN disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
CN-1537097-A Method for producing acid anhydride ��ʽ�����ɽ 2004-10-13 CN disclosed
CN-1166633-C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them ɪά��ʵ���� 2004-09-15 CN disclosed
CN-1387516-A Substd. 5-benzyl-2,4-diaminopyrimidines BASLIDE PHARMA AG (CH) 2002-12-25 CN disclosed
CN-1377879-A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them SEWIL LAB (FR) 2002-11-06 CN disclosed